This Website uses cookies which are essential for providing our services and core website functionality. In addition, if you click on "I AGREE", we will further use analytical and advertising cookies to analyse your use of our Website so that we can improve its functionality and display content tailored according to your interests and preferences, including on third party websites. We use Google Analytics and its tracking and remarketing features connected with Google Ads. This means that cookies on your device will be placed and accessed by Google LLC in the USA enabling us and third parties participating in the Google advertising network to conduct conversion tracking and remarketing activities across different websites and devices. By accepting analytical and advertising cookies you consent to the respective processing and sharing of your personal data with Google LLC. You can withdraw your consent and change your cookie preferences at any time by using our Cookie preferences tool . To refuse consent and continue without analytical and advertising cookies, please click on "I DO NOT AGREE". For more information see our Privacy policy .

logo

Passion for Innovation. Compassion for Patients.™

Daiichi Sankyo UK Ltd.

UK Products

This page is intended for members of the public.

Medical Information can be contacted at medinfo@daiichi-sankyo.co.uk or on 0800 028 5122.

If you experience any adverse effects whilst taking a Daiichi Sankyo product, please report the event to:

Tel: 0800 028 5122
Email: pharmacovigilance@daiichi-sankyo.co.uk

Information on the reporting of adverse events can be obtained from https://yellowcard.mhra.gov.uk/

If you have a question about your medicine, or you are worried about your health, please speak to your doctor or pharmacist. Your doctor or pharmacist is in the best position to help you as they know your medical history.

Products

Product Name Summary of Product Characteristics   Patient Information Leaflet 
Efient (prasugrel hydrochloride) SmPC PIL
Evista (raloxifene hydrochloride) SmPC PIL

Enhertu▼ (trastuzumab deruxtecan)

 SmPC PIL
Lixiana (edoxaban tosilate) SmPC PIL
Motifene (diclofenic sodium) SmPC PIL
Nilemdo▼ (bempedoic acid) SmPC  PIL
Nustendi▼ (bempedoic acid, ezetimibe) SmPC  PIL
Olmetec (olmesartan medoximil) SmPC PIL
Olmetec Plus (hydrochlorothiazide, olmesartan medoximil) SmPC PIL
Sevikar (amplodipine besilate, olmesartan medoximil) SmPC PIL
Sevikar HCT (amplodipine besilate, hydrochlorothiazide, olmesartan medoximil) SmPC PIL

 

DSC/21/0128 March 2021